©2019 by emerge life sciences.

logo.png

Address

This is the address 

Phone

000-000-0000

Fax

000-000-0000

Timeline

2018

UoT Team started incubation

ModMab has licensed 3 programs/molecules and has the option to license up to 7 more (from a large set) over 12 months

 

Team is focused on moving two antibody programs

complete pre-IND studies in 10-12 months

move one molecule (MoM-1) to IND in 24 months

move a second molecule (MoM-2) to IND 28-30 months

 

Rapidly build bispecific onco-immunology drugs (24 months)

Recent Press

Study identifies a targetable lung cancer mutation

Hiranjith GH | Oct, 2018 | Medgenome

Study identifies a targetable lung cancer mutation

Hiranjith GH | Oct, 2018 | Medgenome

Study identifies a targetable lung cancer mutation

Hiranjith GH | Oct, 2018 | Medgenome

Recent Press

Study identifies a targetable lung cancer mutation

Hiranjith GH | Oct, 2018 | Medgenome